|
|
||||||||
Nuclear Medicine Division of the Department of Radiology, the Clinical Investigation and Arthritis Units of the Medical Service and the Surgical Service, Massachusetts General Hospital
Shriners Burns Institute, Boston, Massachusetts
R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey
Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania
Correspondence: For correspondence or reprints contact: Alan J. Fischman, MD, PhD, Div. of Nuclear Medicine, Massachusetts General Hospital, Fruit St., Boston, MA 02114.
ABSTRACT
We synthesized and evaluated four hydrazino nicotinamide (HYNIC) derivatized chemotactic peptide analogs: For-NIeLFK-HYNIC (HP1), For-MLFK-HYNIC (HP2), For-MLFNH(CH2)6NH-HYNIC (HP3), and For-MLF-(D)-K-HYNIC (HP4), for in vitro bioactivity and receptor binding. The peptides were radiolabeled with 99mTc via a glucoheptonate co-ligand and their biodistribution determined in rats (n = 6/time point) at 5, 30, 60 and 120 min after injection. Localization of the peptides at sites of deep thigh Escherichia coli infection was determined by radioactivity measurements on excised tissues in rats (n = 6/time point) and rabbits as well as scintillation camera imaging in rabbits (n = 6). All peptides maintained biological activity (EC50s for O2 production by human PMNs: 12500 nM) and the ability to bind to the oligopeptide chemoattractant receptor on human PMNS (EC50s for binding: 0.1240 nM). After incubation with 99mTc-glucoheptonate, radiolabeled peptides were isolated by HPLC at specific activities of > 10,000 mCi/µM. Technetium-99m-labeled peptides retained receptor binding with EC50s < 10 nM. Blood clearance of all four peptides was rapid. Biodistributions of the individual peptides were similar, with low levels of accumulation in most normal tissues. In rats, all of the peptides concentrated at the infection sites (T/B ratio: 2.53:1) within 1 hr of injection. In rabbits, outstanding images of the infection sites were obtained, with T/B ratios of >20:1 at 15 hr after injection. This study demonstrates that 99mTc-labeled chemotactic peptide analogs are effective agents for the external imaging of focal sites of infection.
This article has been cited by other articles:
![]() |
M. Zhao, Z. Li, and S. Bugenhagen 99mTc-Labeled Duramycin as a Novel Phosphatidylethanolamine-Binding Molecular Probe J. Nucl. Med., August 1, 2008; 49(8): 1345 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hartwig, E. A. Carter, R. E. Jimenez, J. Werner, A. J. Fischman, C. F.-D. Castillo, and A. L. Warshaw Chemotactic peptide uptake in acute pancreatitis: correlation with tissue accumulation of leukocytes J Appl Physiol, August 1, 1999; 87(2): 743 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Kaim, B. Weber, M. O. Kurrer, J. Gottschalk, G. K. von Schulthess, and A. Buck Autoradiographic Quantification of Radiology, May 1, 2002; 223(2): 446 - 451. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |